Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()

OBJECTIVE: To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups. STUDY DESIGN: We measured MPA in previously colle...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Contraception
Glavni autori: Nanda, Kavita, Callahan, Rebecca, Taylor, Douglas, Wang, Meng, Agot, Kawango, Jenkins, David, Van Damme, Lut, Dorflinger, Laneta
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Original Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894753/
https://ncbi.nlm.nih.gov/pubmed/26972780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2016.03.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items